You Need To Trust The Government (They Know Better)

Jim O'Neill spent years as a longevity advocate and now, as HHS deputy secretary, helped deliver the first dietary guidelines in a generation that break from the low-fat, high-grain dogma. He explains that regulatory capture fueled decades of advice that harmed public health—fat was demonized while sugar and ultra-processed grains were pushed. The new guidelines are based on real science, not political convenience, and explicitly say whole foods, meat, and full-fat dairy are fine, while grains are not the core of a balanced diet and food dyes are not great. He sees this as providing actionable clarity for families overwhelmed by misleading grocery store marketing. The guidelines also raised protein recommendations to 1.2–1.6 g/kg/day. Jim himself eats this way: 'protein and healthy fats, minimize grain and processed foods, minimize sugar.' He acknowledges it’s still early for detail on protein quality, but the direction is set.

Vitamin D emerged as Jim’s personal favorite supplement during a casual exchange. He says, 'Every few months I learn about more additional benefits of vitamin D.' He appreciates its low cost and testability. The conversation immediately turned to policy: Dave noted the recommended upper limits seem frozen since 1960, and Jim confirmed they are reviewing them right now. This is significant for practitioners who have long felt the caps are unjustifiably low. Jim’s openness suggests that future recommendations could rise, providing more room for supplementation. While no dose details are given, the protocol is to supplement and test.

Jim O'Neill wears an Oura ring primarily for sleep tracking. He described a simple, concrete use case: some mornings he wakes a bit early and isn't sure whether to go back to sleep or get up. Instead of guessing, he checks the ring to see how many hours of sleep he got and what types of sleep occurred, then decides. This is a low-effort biohack that turns wearable data into an actionable daily habit. Dave, an early investor in Oura, emphasizes privacy—tracking is helpful for personal use but should not become involuntary surveillance. Jim agrees, stressing informed consent and anonymization. This protocol avoids the privacy trap by keeping data personal.

O'Neill explains that the every-five-year update usually produced 'terrible, unscientific' guidelines centered on grains, leading to massive chronic disease driven by bad diet. This time, the Trump administration and Secretary Kennedy brought a coalition that made it politically possible to pursue real science without fear of entrenched interests. The collaboration with USDA produced guidelines that finally tell people whole foods are good, grain is not the center, food dyes are problematic, and it's okay to eat meat and full-fat dairy. He frames this as giving permission to families who want to be healthier but were lost amid misleading marketing. Some expressed concern, but the department stands by the science. The shift is so stark that he acknowledges to people like Dave, 'this is like you’ve known this for 25 years, but for a lot of people it’s new.'

O'Neill argues that all chronic diseases are pathologies of aging, so tackling aging damage at the cellular level addresses both lifespan and the burden of diabetes, sarcopenia, osteoporosis, etc. He explains that without causal biomarkers, testing an anti-aging drug would require a lifetime to see if people live longer, which is impractical. The $144 million program at ARPA-H (the government’s life science VC arm) will find these biomarkers, then run them through FDA's biomarker validation program so they become public, non-proprietary targets. This will allow companies to develop and replicate therapies, then get them approved as drugs or devices. He sees this as thrilling for longevity enthusiasts while also tackling chronic disease for everyone. Dave asks if current DNA methylation clocks are enough; O'Neill flatly says 'They are not good enough.'

During the discussion on right-to-try and peptides, Dave argues that small companies can't afford RCTs, and if no patent exists, 'it helps the world, but it harms the innovator'—a perfect niche for government. He suggests studying 'this kind of food or this supplement' to prove what's generally healthy. Jim acknowledges the logic and says he does see HHS moving toward that model. This aligns with Secretary Kennedy's advocacy for informed consent and openness to ideas that start on 'the so-called fringe.' The conversation ties into broader openness for non-pharmaceutical approaches like ozone therapy and red/infrared light, which Jim says have no reason not to be tested like anything else.

When Dave asks Jim about the government's stance on vitamin D upper limits, Jim says plainly, 'We are reviewing that right now.' Dave offers to help, along with thousands of functional medicine doctors. Jim’s personal enthusiasm for vitamin D as his favorite supplement adds weight; he says it's cheap, easy to measure, and has a growing list of benefits. The review suggests the current administration is open to updating science-based ceilings that have not kept pace with research.

Jim mentions Utah's three-week-old law as an example of AI progress, alongside internal deployment of large language models for 65,000 HHS employees and work with Medicare to create reimbursement codes for AI. While the goal is to 'practice at the top of the license,' he emphasizes there should still be a doctor in the loop for decision support, at least for now. The refill-without-human step is a significant leap that the department appears to support, signaling an appetite for pragmatic deregulation.